The Helsinki Stroke Thrombolysis Registry Group includes also: Ville Artto, Olli Häppölä, Perttu J. Lindsberg, Katja Piironen, Janne Pitkäniemi, Kirsi Rantanen, Tiina Sairanen, Oili Salonen, Heli Silvennoinen, Lauri Soinne, Daniel Strbian.
Does time of day or physician experience affect outcome of acute ischemic stroke patients treated with thrombolysis? A study from Finland
Article first published online: 11 APR 2012
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization
International Journal of Stroke
Volume 7, Issue 6, pages 511–516, August 2012
How to Cite
, Helsinki Stroke Thrombolysis Registry Group (2012), Does time of day or physician experience affect outcome of acute ischemic stroke patients treated with thrombolysis? A study from Finland. International Journal of Stroke, 7: 511–516. doi: 10.1111/j.1747-4949.2012.00795.x
Conflict of interest: Yes.
Sources of Funding: This study was funded by the Helsinki University Central Hospital EVO Research Fund.
Disclosure: Dr Atula, Dr Curtze, Dr Leppä, Mr Lindberg, Dr Mustanoja, Dr Putaala, and Dr Tiainen report no conflicts of interest. Dr Meretoja has received modest consultant fees and honoraria for speaking in educational symposia from Boehringer Ingelheim. Dr Tatlisumak has received modest research grant from Boehringer Ingelheim, has research contracts with SanofiAventis, H. Lundbeck Ab, Schering Plough, Mitsubishi Pharma Europe, BrainsGate Inc, and Concentric Medical Inc, served as a consultant to Mitsubishi Pharma Europe, Boehringer Ingelheim. Dr Kaste received honoraria from Boehringer Ingelheim, PAION AG, Forest Research Laboratories Inc, and Lundbeck AS for participating in Steering Committee meetings of all ECASS and Desmoteplase in Acute Ischemic Stroke Trial (DIAS) trials (modest), and is a consultant and on the Advisory Boards of Boehringer Ingelheim, PAION AG, Forest Research Laboratories Inc, and Lundbeck AS (modest).
- Issue published online: 16 JUL 2012
- Article first published online: 11 APR 2012
- Helsinki University Central Hospital EVO Research Fund
|ijs795-sup-001-Table-S1.docx||161K||Table S1. Baseline and treatment characteristics|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.